NeoStem, Utek Corp. deal

NBS acquired UTK's Stem Cell Technologies Inc. subsidiary for 400,000 shares valued at $940,000 based on NBS's closing price of $2.35 on Nov. 13, the last trading day before the deal was announced. St...